To explore the potential effects of ANKRD22 on the progression and development of breast cancer, we analyzed ANKRD22 mRNA expression levels in 70 clinical samples, including 53 breast cancer tissue samples and 17 normal breast tissue samples. Here, ANKRD22 is linked to breast carcinoma.